PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33081568-0	2021	Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib.	Erlotinib Hydrochloride	84-93	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	23-28	
33081568-0	2021	Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib.	Erlotinib Hydrochloride	84-93	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	148-153	
33081568-0	2021	Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib.	Erlotinib Hydrochloride	175-184	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	23-28	
33081568-0	2021	Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib.	Erlotinib Hydrochloride	175-184	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	148-153	
33081568-4	2021	co-infusion of erlotinib and tariquidar by studying brain distribution of the model ABCB1/ABCG2 substrate [11C]erlotinib in mice and rhesus macaques with PET.	Erlotinib Hydrochloride	15-24	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	84-89	
33081568-4	2021	co-infusion of erlotinib and tariquidar by studying brain distribution of the model ABCB1/ABCG2 substrate [11C]erlotinib in mice and rhesus macaques with PET.	Erlotinib Hydrochloride	111-120	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	84-89	
33081568-9	2021	Co-infusion of erlotinib/tariquidar may potentially allow for complete ABCB1/ABCG2 inhibition at the BBB, while simultaneously achieving brain-targeted EGFR inhibition.	Erlotinib Hydrochloride	15-24	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	71-76